Literature DB >> 20860486

Antibiotic resistance in Chlamydiae.

Kelsi M Sandoz1, Daniel D Rockey.   

Abstract

There are few documented reports of antibiotic resistance in Chlamydia and no examples of natural and stable antibiotic resistance in strains collected from humans. While there are several reports of clinical isolates exhibiting resistance to antibiotics, these strains either lost their resistance phenotype in vitro, or lost viability altogether. Differences in procedures for chlamydial culture in the laboratory, low recovery rates of clinical isolates and the unknown significance of heterotypic resistance observed in culture may interfere with the recognition and interpretation of antibiotic resistance. Although antibiotic resistance has not emerged in chlamydiae pathogenic to humans, several lines of evidence suggest they are capable of expressing significant resistant phenotypes. The adept ability of chlamydiae to evolve to antibiotic resistance in vitro is demonstrated by contemporary examples of mutagenesis, recombination and genetic transformation. The isolation of tetracycline-resistant Chlamydia suis strains from pigs also emphasizes their adaptive ability to acquire antibiotic resistance genes when exposed to significant selective pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860486      PMCID: PMC3075073          DOI: 10.2217/fmb.10.96

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  118 in total

Review 1.  Genome sequencing and our understanding of chlamydiae.

Authors:  D D Rockey; J Lenart; R S Stephens
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Authors:  Paul F Riska; Andrei Kutlin; Patrick Ajiboye; Arnold Cua; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 3.  Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.

Authors:  William M Geisler
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism.

Authors:  João P Gomes; Alexandra Nunes; William J Bruno; Maria J Borrego; Carlos Florindo; Deborah Dean
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

5.  Protein signatures distinctive of chlamydial species: horizontal transfers of cell wall biosynthesis genes glmU from archaea to chlamydiae and murA between chlamydiae and Streptomyces.

Authors:  Emma Griffiths; Radhey S Gupta
Journal:  Microbiology       Date:  2002-08       Impact factor: 2.777

6.  Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.

Authors:  David M Rothstein; Robert J Suchland; Minsheng Xia; Christopher K Murphy; Walter E Stamm
Journal:  J Antibiot (Tokyo)       Date:  2008-08       Impact factor: 2.649

Review 7.  Parachlamydia acanthamoebae, an emerging agent of pneumonia.

Authors:  G Greub
Journal:  Clin Microbiol Infect       Date:  2009-01       Impact factor: 8.067

8.  Loss of virulence during culture of Aeromonas salmonicida at high temperature.

Authors:  E E Ishiguro; W W Kay; T Ainsworth; J B Chamberlain; R A Austen; J T Buckley; T J Trust
Journal:  J Bacteriol       Date:  1981-10       Impact factor: 3.490

9.  Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine.

Authors:  H H Lee; M A Chernesky; J Schachter; J D Burczak; W W Andrews; S Muldoon; G Leckie; W E Stamm
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

10.  Detection of circulating Chlamydophila pneumoniae in patients with coronary artery disease and healthy control subjects.

Authors:  Sarah Klizas West; Sue J Kohlhepp; Ruyun Jin; Curt A Gleaves; Walter Stamm; David N Gilbert
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

View more
  53 in total

1.  Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.

Authors:  Kelsi M Sandoz; Steven G Eriksen; Brendan M Jeffrey; Robert J Suchland; Timothy E Putman; Dennis E Hruby; Robert Jordan; Daniel D Rockey
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

Review 2.  A Coming of Age Story: Chlamydia in the Post-Genetic Era.

Authors:  Anna J Hooppaw; Derek J Fisher
Journal:  Infect Immun       Date:  2015-12-14       Impact factor: 3.441

Review 3.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

Review 4.  Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment.

Authors:  Monica M Laronda; Joanna E Burdette; J Kim; Teresa K Woodruff
Journal:  Stem Cell Res Ther       Date:  2013-12-20       Impact factor: 6.832

5.  Novel Detection Strategy To Rapidly Evaluate the Efficacy of Antichlamydial Agents.

Authors:  Yan Zhang; Yuqi Xian; Leiqiong Gao; Hiba Elaasar; Yao Wang; Lamiya Tauhid; Ziyu Hua; Li Shen
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

6.  N-Acylated Derivatives of Sulfamethoxazole Block Chlamydia Fatty Acid Synthesis and Interact with FabF.

Authors:  Sergio A Mojica; Olli Salin; Robert J Bastidas; Naresh Sunduru; Mattias Hedenström; C David Andersson; Carlos Núñez-Otero; Patrik Engström; Raphael H Valdivia; Mikael Elofsson; Åsa Gylfe
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

7.  Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis.

Authors:  Yesid A Ramirez; Thomas B Adler; Eva Altmann; Theresa Klemm; Christian Tiesmeyer; Florian Sauer; Stefan G Kathman; Alexander V Statsyuk; Christoph Sotriffer; Caroline Kisker
Journal:  ChemMedChem       Date:  2018-09-06       Impact factor: 3.466

8.  Biological effects of chlamydiaphage phiCPG1 capsid protein Vp1 on chlamydia trachomatis in vitro and in vivo.

Authors:  Sheng Wang; Rui Guo; Yuan-Li Guo; Li-Li Shao; Yang Liu; Shi-Juan Wei; Yuan-Jun Liu; Quan-Zhong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

9.  Activities of first-choice antimicrobials against gamma interferon-treated Chlamydia trachomatis differ in hypoxia.

Authors:  Kensuke Shima; Matthias Klinger; Werner Solbach; Jan Rupp
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

10.  Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.

Authors:  Jian Lin Li; Ningjing Yang; Lei Huang; Dandan Chen; Yu Zhao; M Matt Tang; Huizhou Fan; Xiaofeng Bao
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.